# Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?

> **NCT02554383** · PHASE3 · COMPLETED · sponsor: **Nader Shaikh** · enrollment: 515 (actual)

## Conditions studied

- Sinusitis
- Respiratory Tract Infections

## Interventions

- **DRUG:** Amoxicillin-clavulanate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02554383
- **Lead sponsor:** Nader Shaikh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2022-03-31
- **Final completion:** 2023-03-09
- **Target enrollment:** 515 (ACTUAL)
- **Last updated:** 2023-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02554383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02554383, "Efficacy of Antibiotics in Children With Acute Sinusitis: Which Subgroups Benefit?". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02554383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*